Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' Equity

v3.24.3
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Warrants
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Controlling Interest
Total
Balance at beginning of period at Dec. 31, 2022 $ 858,143 $ 225,127 $ 796 $ 988 $ (963,703) $ 166 $ 121,517
Balance at beginning of period (in shares) at Dec. 31, 2022 377,515,391            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   31         31
Warrants expired   67 (67)        
Issuance and vesting (forfeiture) of restricted share units $ 209           209
Issuance and vesting (forfeiture) of restricted share units (in shares) 370,744            
Shares reserved for contingent consideration $ 53           53
Warrants issued as part of debt modification     5,106       5,106
Comprehensive income (loss) for the period       (2) (4,875) 9 (4,868)
Balance at end of the period at Mar. 31, 2023 $ 858,405 225,225 5,835 986 (968,578) 175 122,048
Balance at end of period (in shares) at Mar. 31, 2023 377,886,135            
Balance at beginning of period at Dec. 31, 2022 $ 858,143 225,127 796 988 (963,703) 166 121,517
Balance at beginning of period (in shares) at Dec. 31, 2022 377,515,391            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income (loss) for the period             (41,878)
Balance at end of the period at Sep. 30, 2023 $ 856,208 225,254 5,835 976 (1,004,136)   84,137
Balance at end of period (in shares) at Sep. 30, 2023 381,463,838            
Balance at beginning of period at Mar. 31, 2023 $ 858,405 225,225 5,835 986 (968,578) 175 122,048
Balance at beginning of period (in shares) at Mar. 31, 2023 377,886,135            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   3         3
Issuance and vesting (forfeiture) of restricted share units $ (1,074)           (1,074)
Issuance and vesting (forfeiture) of restricted share units (in shares) 642,726            
Shares reserved for contingent consideration $ (1,287)           (1,287)
Comprehensive income (loss) for the period       (3) (26,895) (1,442) (28,340)
Balance at end of the period at Jun. 30, 2023 $ 856,044 225,228 5,835 983 (995,473) (1,267) 91,350
Balance at end of period (in shares) at Jun. 30, 2023 378,528,861            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   26         26
Issuance and vesting (forfeiture) of restricted share units $ 164           164
Issuance and vesting (forfeiture) of restricted share units (in shares) 2,934,977            
CGSF/SFNY Divestiture           $ 1,267 1,267
Comprehensive income (loss) for the period       (7) (8,663)   (8,670)
Balance at end of the period at Sep. 30, 2023 $ 856,208 225,254 5,835 976 (1,004,136)   84,137
Balance at end of period (in shares) at Sep. 30, 2023 381,463,838            
Balance at beginning of period at Dec. 31, 2023 $ 856,422 225,250 5,835 973 (1,026,087)   62,393
Balance at beginning of period (in shares) at Dec. 31, 2023 384,833,546            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   17         17
Issuance and vesting (forfeiture) of restricted share units $ 90           90
Issuance and vesting (forfeiture) of restricted share units (in shares) 2,613,463            
Comprehensive income (loss) for the period       (7) (9,651)   (9,658)
Balance at end of the period at Mar. 31, 2024 $ 856,512 225,267 5,835 966 (1,035,738)   52,842
Balance at end of period (in shares) at Mar. 31, 2024 387,447,009            
Balance at beginning of period at Dec. 31, 2023 $ 856,422 225,250 5,835 973 (1,026,087)   62,393
Balance at beginning of period (in shares) at Dec. 31, 2023 384,833,546            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income (loss) for the period             (58,254)
Balance at end of the period at Sep. 30, 2024 $ 856,558 226,105 5,106 966 (1,084,334)   4,401
Balance at end of period (in shares) at Sep. 30, 2024 390,558,148            
Balance at beginning of period at Mar. 31, 2024 $ 856,512 225,267 5,835 966 (1,035,738)   52,842
Balance at beginning of period (in shares) at Mar. 31, 2024 387,447,009            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   3         3
Issuance and vesting (forfeiture) of restricted share units $ 20           20
Issuance and vesting (forfeiture) of restricted share units (in shares) 3,044,399            
Comprehensive income (loss) for the period       (1) (35,947)   (35,948)
Balance at end of the period at Jun. 30, 2024 $ 856,532 225,270 5,835 965 (1,071,685)   16,917
Balance at end of period (in shares) at Jun. 30, 2024 390,491,408            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   106         106
Warrants expired   729 (729)        
Issuance and vesting (forfeiture) of restricted share units $ 26           26
Issuance and vesting (forfeiture) of restricted share units (in shares) 66,740            
Comprehensive income (loss) for the period       1 (12,649)   (12,648)
Balance at end of the period at Sep. 30, 2024 $ 856,558 $ 226,105 $ 5,106 $ 966 $ (1,084,334)   $ 4,401
Balance at end of period (in shares) at Sep. 30, 2024 390,558,148